We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of CAS Medical Systems, Inc. (“CASMED” or the “Company”) (NASDAQCM: CASM) to Edwards Lifesciences Corporation (NYSE: EW). Under the terms of the transaction, CASMED shareholders will receive per $2.45 per share.
The CASMED merger investigation concerns whether the Board of CASMED breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Edwards Lifesciences Corporation is underpaying for CASMED shares, thus unlawfully harming CASMED shareholders.
To receive more information, please fill out the form.